Lai MY - Search Results

1

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

Hassanein T, Cooksley G, Sulkowski M, Smith C, Marinos G, Lai MY, Pastore G, Trejo-Estrada R, Horta E Vale A, Wintfeld N, Green J. Hassanein T, et al. Among authors: lai my. J Hepatol. 2004 Apr;40(4):675-81. doi: 10.1016/j.jhep.2003.12.014. J Hepatol. 2004. PMID: 15030985 Clinical Trial.

2

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.

Schalm SW, Weiland O, Hansen BE, Milella M, Lai MY, Hollander A, Michielsen PP, Bellobuono A, Chemello L, Pastore G, Chen DS, Brouwer JT. Schalm SW, et al. Among authors: lai my. Gastroenterology. 1999 Aug;117(2):408-13. doi: 10.1053/gast.1999.0029900408. Gastroenterology. 1999. PMID: 10419923 Clinical Trial.

3

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.

Yang SS, Lai MY, Chen DS, Chen GH, Kao JH. Yang SS, et al. Among authors: lai my. Liver Int. 2003 Dec;23(6):426-33. doi: 10.1111/j.1478-3231.2003.00875.x. Liver Int. 2003. PMID: 14986817

4

Firstline treatment for hepatitis C: combination interferon/ribavirin versus interferon monotherapy.

Lai MY. Lai MY. J Gastroenterol Hepatol. 2000 May;15 Suppl:E130-3. doi: 10.1046/j.1440-1746.2000.02136.x. J Gastroenterol Hepatol. 2000. PMID: 10921396

5

Hepatitis B genotypes and the response to interferon therapy.

Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Kao JH, et al. Among authors: lai my. J Hepatol. 2000 Dec;33(6):998-1002. doi: 10.1016/s0168-8278(00)80135-x. J Hepatol. 2000. PMID: 11131465

6

Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.

Kao JH, Lai MY, Chen W, Chen PJ, Chen DS. Kao JH, et al. Among authors: lai my. J Gastroenterol Hepatol. 1998 Dec;13(12):1249-53. J Gastroenterol Hepatol. 1998. PMID: 9918434

7

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

Liu CJ, Lai MY, Chao YC, Liao LY, Yang SS, Hsiao TJ, Hsieh TY, Lin CL, Hu JT, Chen CL, Chen PJ, Kao JH, Chen DS. Liu CJ, et al. Among authors: lai my. Hepatology. 2006 Apr;43(4):742-9. doi: 10.1002/hep.21100. Hepatology. 2006. PMID: 16557544 Clinical Trial.

8

Efficacy of consensus interferon in the treatment of chronic hepatitis C.

Kao JH, Chen PJ, Lai MY, Chen DS. Kao JH, et al. Among authors: lai my. J Gastroenterol Hepatol. 2000 Dec;15(12):1418-23. doi: 10.1046/j.1440-1746.2000.02371.x. J Gastroenterol Hepatol. 2000. PMID: 11197053 Clinical Trial.

9

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.

Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS. Liu CJ, et al. Among authors: lai my. Hepatology. 2003 Mar;37(3):568-76. doi: 10.1053/jhep.2003.50096. Hepatology. 2003. PMID: 12601355

10

HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan.

Veenstra DL, Sullivan SD, Lai MY, Lee CM, Tsai CM, Patel KK. Veenstra DL, et al. Among authors: lai my. Value Health. 2008 Mar-Apr;11(2):131-8. doi: 10.1111/j.1524-4733.2007.00221.x. Value Health. 2008. PMID: 18380625 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters